Markus Schwaiger
Markus Schwaiger
UCLA,University of Michigan,Technische Universität München
Adresse e-mail validée de tum.de
Titre
Citée par
Citée par
Année
Reversibility of cardiac wall-motion abnormalities predicted by positron tomography
J Tillisch, R Brunken, R Marshall, M Schwaiger, M Mandelkern, M Phelps, ...
New England Journal of Medicine 314 (14), 884-888, 1986
15791986
Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma
ME Juweid, S Stroobants, OS Hoekstra, FM Mottaghy, M Dietlein, ...
Journal of Clinical Oncology 25 (5), 571-578, 2007
14422007
Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo
ML von Brühl, K Stark, A Steinhart, S Chandraratne, I Konrad, M Lorenz, ...
Journal of Experimental Medicine 209 (4), 819-835, 2012
10852012
Evaluation of hybrid 68Ga-PSMA ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy
M Eiber, T Maurer, M Souvatzoglou, AJ Beer, A Ruffani, B Haller, ...
Journal of nuclear medicine 56 (5), 668-674, 2015
8472015
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial
F Lordick, K Ott, BJ Krause, WA Weber, K Becker, HJ Stein, S Lorenzen, ...
The lancet oncology 8 (9), 797-805, 2007
7992007
Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography
C Klein, SG Nekolla, FM Bengel, M Momose, A Sammer, F Haas, ...
Circulation 105 (2), 162-167, 2002
7862002
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging
WA Weber, K Ott, K Becker, HJ Dittler, H Helmberger, NE Avril, ...
Journal of clinical oncology 19 (12), 3058-3065, 2001
7822001
Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner
G Delso, S Fürst, B Jakoby, R Ladebeck, C Ganter, SG Nekolla, ...
Journal of nuclear medicine 52 (12), 1914-1922, 2011
7472011
Noninvasive imaging of αvβ3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography
R Haubner, HJ Wester, WA Weber, C Mang, SI Ziegler, SL Goodman, ...
Cancer research 61 (5), 1781-1785, 2001
7462001
Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data
A Martinez-Möller, M Souvatzoglou, G Delso, RA Bundschuh, ...
Journal of nuclear medicine 50 (4), 520-526, 2009
6782009
Positron Emission Tomography Using [18F]Fluorodeoxyglucose for Monitoring Primary Chemotherapy in Breast Cancer
M Schelling, N Avril, J Nahrig, W Kuhn, W Romer, D Sattler, M Werner, ...
Journal of Clinical Oncology 18 (8), 1689-1695, 2000
6392000
Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography
D Eitzman, Z Al-Aouar, HL Kanter, J vom Dahl, M Kirsh, GM Deeb, ...
Journal of the American College of Cardiology 20 (3), 559-565, 1992
6201992
Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging
GD Hutchins, M Schwaiger, KC Rosenspire, J Krivokapich, H Schelbert, ...
Journal of the American College of Cardiology 15 (5), 1032-1042, 1990
6001990
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study
A Drzezga, N Lautenschlager, H Siebner, M Riemenschneider, F Willoch, ...
European journal of nuclear medicine and molecular imaging 30 (8), 1104-1113, 2003
5992003
Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations
N Avril, CA Rose, M Schelling, J Dose, W Kuhn, S Bense, W Weber, ...
Journal of clinical oncology 18 (20), 3495-3502, 2000
5952000
Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics
R Haubner, HJ Wester, F Burkhart, R Senekowitsch-Schmidtke, W Weber, ...
Journal of Nuclear Medicine 42 (2), 326-336, 2001
5782001
Positron emission tomography in non–small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use
WA Weber, V Petersen, B Schmidt, L Tyndale-Hines, T Link, C Peschel, ...
Journal of Clinical Oncology 21 (14), 2651-2657, 2003
5682003
Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction
A Schömig, A Kastrati, J Dirschinger, J Mehilli, U Schricke, J Pache, ...
New England Journal of Medicine 343 (6), 385-391, 2000
5642000
Noninvasive visualization of the activated αvβ3 integrin in cancer patients by positron emission tomography and [18 F] Galacto-RGD
R Haubner, WA Weber, AJ Beer, E Vabuliene, D Reim, M Sarbia, ...
PLoS Med 2 (3), e70, 2005
5602005
Synthesis and radiopharmacology of O-(2-[18F] fluoroethyl)-L-tyrosine for tumor imaging
HJ Wester, M Herz, W Weber, P Heiss, R Senekowitsch-Schmidtke, ...
Journal of Nuclear Medicine 40 (1), 205-212, 1999
5591999
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20